Approval Of Unaudited Standalone Financial Result of the Company for the Quarter Ended On 31St December 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board of Chemiesynth (Vapi) Ltd approved the unaudited financial results for the quarter and nine months ended 31 December 2025. Revenue from operations for Q3 FY26 stood at Rs 508.66 lakhs, down sharply from Rs 687.15 lakhs in Q3 FY25 — a year-on-year decline of roughly 26%. The company reported a net loss of Rs 69.71 lakhs for the quarter, widening from a loss of Rs 43.95 lakhs in the year-ago quarter. For the nine months ended December 2025, the loss ballooned to Rs 159.29 lakhs with revenue at Rs 1,752.56 lakhs. The statutory auditor, Manoj Shah & Co, issued an unqualified limited review report. The board also reconstituted the Nomination & Remuneration Committee.
Negative for shareholders — the company continues to report widening quarterly losses on a declining revenue base, signalling ongoing operational stress. The small size of revenue (under Rs 2 crore per quarter) and absence of profitability make this a high-risk micro-cap chemical stock to watch closely.